WELCOME TO THE

DELVE BLOG

Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle

—Not the Other Way Around
A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials paused or indefinitely delayed in June 2020—impacting nearly 1,000 companies. Disruptions included delayed initiation or complete withdrawal of planned trials, as well as suspended enrollment or cancellation of on-going trials. The number of disrupted trials has been falling slowly since June 2020, with most current disruptions due to other factors, such as slow enrollment.

Mobile Strategy for Clinical Trials

Mobile technologies are gaining greater acceptance and adoption in clinical trials, to engage patients, investigators, and study team 90% of SMS are opened within 3 minutes 85% of people prefer SMS over email or phone calls 56% of the world population owns a smartphone Every clinical trial needs a mobile strategy to get to patients, investigators, and study teams. Collect digital endpoint Notify Investigators of AE Upcoming visit notification Improve Medication adherence Study team updates of any serious adverse events 50,000 health apps as of 2020 Virtually everyone has a smartphone these days, which theoretically means that investing in the

eConsent in Virtual Clinical Trial

Per the FDA guidance, an electronic consent is any “the use of electronic systems and processes that may employ multiple electronic media to obtain informed consent for both HHS-regulated human subject research and FDA-regulated clinical investigations of medical products, including human drug and biological products, medical devices, and combinations thereof.”   eConsent is gaining greater acceptance and adoption in clinical trials 90% of top 10 pharma have an eConsent initiative in place 88% of top 25 pharma implemented eConsent 66% of top 50 pharma companies are engaged in planning an eConsent initiative Every clinical trial is different, but implementing the right

Scroll to Top